| Accession Number: | 0001209191-20-011796 |
| Date: | 2020-02-19 |
| Issuer: | CHEMOCENTRYX, INC. (CCXI) |
| Original Submission Date: |
SCHALL THOMAS J.
C/O CHEMOCENTRYX, INC.
850 MAUDE AVENUE
MOUNTAIN VIEW, CA 94043
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-02-19 | M | 63,340 | a | $14.31 | 2,331,897 | direct | ||
| COMMON STOCK | 2020-02-19 | S | 55,617 | d | $50.41 | 2,276,280 | direct | ||
| COMMON STOCK | 2020-02-19 | S | 7,723 | d | $51.14 | 2,268,557 | direct | ||
| COMMON STOCK | 2020-02-20 | M | 15,341 | a | $14.31 | 2,283,898 | direct | ||
| COMMON STOCK | 2020-02-20 | S | 15,312 | d | $50.21 | 2,268,586 | direct | ||
| COMMON STOCK | 2020-02-20 | S | 29 | d | $51.10 | 2,268,557 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 14.31 | 2020-02-19 | deemed execution date | M | 63,340 (d) | 2022-07-24 | common stock 63,340 | $14.31 | 302,223 | direct | ||
| STOCK OPTION (RIGHT TO BUY) | 14.31 | 2020-02-20 | deemed execution date | M | 15,341 (d) | 2022-07-24 | common stock 15,341 | $14.31 | 286,882 | direct |
| ID | footnote |
|---|---|
| f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
| f2 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $49.99 to $50.97 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| f3 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $50.99 to $51.36 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| f4 | reflects the weighted average sale price of the sales sold. the shares were sold in multiple trades at prices ranging from $49.99 to $50.92 per share. the reporting person will provide to the sec staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. |
| f5 | as of february 19, 2020, and prior to this transaction, the exercised options were fully vested. |
| f6 | not applicable. |
